Healables

Healables

Closed: Apr. 2024

About this raise

Healables, with a valuation of $29.27 million, is raising funds on Dalmore Group. The company has developed personalized technology to turn down pain and turn up performance using wearables and without any medication. Healables device is currently undergoing trials on patients with knee osteoarthritis and is planned to be continued on patients with diabetic neuropathy and fibromyalgia. The company has already licensed its technology, obtained a CE mark, has been granted patents, and has signed LOIs and NDAs with multiple companies. Moshe Lebowitz founded Healables in June 2022. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $4.8 million. The campaign proceeds will be used for research and development, general and administrative expenses, marketing and sales, licensing and royalties, clinical trials and pilots, inventory, debt repayment, and working capital.

Expand

Investment Overview

Not Funded: $250

Deal Terms

Total Commitments

Platform
Dalmore Group
Start Date
09/27/2023
Close Date
04/30/2024
Min. Goal
$25,000
Max Goal
$4,800,000
Min. Investment

$250

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.50

Pre-Money Valuation

$29,270,000

Company & Team

Company

Year Founded
2022
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Location
Miami, Florida
Business Type
Growth
Company Website
Visit Website

Team

Employees
2
Prior Founder Exits?
Yes
Founder Name
Moshe Lebowitz
Title
CEO

Financials

as of Fiscal Year 2023
 Revenue
$0
 Monthly Burn
$117,352
 Runway
0 months

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-1,408,226

$0

Summary Balance Sheet

FY 2023 FY 2022

Cash

$3,779

$0

Accounts Receivable

$0

$0

Total Assets

$3,779

$0

Short-Term Debt

$0

$0

Long-Term Debt

$661,465

$0

Total Liabilities

$661,465

$0

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$0
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/30/2024 Dalmore Group $29,270,000 $250 Equity - Common Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Healables on Dalmore Group 2023
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $29,270,000
Price per Share: $2.50

Follow company

Follow Healables on Dalmore Group 2023

Buy Healables's Deal Report

Warning: according to the close date for this deal, Healables may no longer be accepting investments.

Healables Deal Report

Get Kingscrowd's comprehensive report on Healables including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Healables is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Healables deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge